Earum Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022
For the full year, sales was INR 210.36 million compared to INR 410.84 million a year ago. Revenue was INR 287.39 million compared to INR 500.16 million a year ago. Net income was INR 22.24 million compared to INR 0.882 million a year ago. Basic earnings per share from continuing operations was INR 0.36 compared to INR 0.014 a year ago. Diluted earnings per share from continuing operations was INR 0.36 compared to INR 0.014 a year ago.